The study did not meet the primary endpoint of change on a measure of how much sugar the brain uses for energy, but it showed that patients on the drug had nearly 50% less shrinking in parts of the brain that control memory and learning and that treated participants had a slightly slower decline in cognitive function
It is not intended for human use, animal use, medical use, diagnostic use, therapeutic use, dietary use, cosmetic use, injection, ingestion, inhalation, or topical application
The most common patient complaints are minor: soreness at injection site, a transient headache, or mild diarrhea
B: GHK-Cu liposome group, 14 days